Evidence map›Paper›PMID 17392033›Full record

ReviewComparative biochemistry and physiology. Toxicology & pharmacology : CBP2007

Marine pharmacology in 2003-4: marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action.

Alejandro M S Mayer, Abimael D Rodríguez, Roberto G S Berlinck, Mark T Hamann

Abstract readReview
In one paragraph

Review in Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Marine Antithrombotics.Marine drugs · 2020
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. New Insights into Sepsis Therapy Using Sepia Officinalis.Jundishapur journal of microbiology · 2016
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alejandro M S MayerDepartment of Pharmacology, Chicago College of Osteopathic Medicine, Midwestern University, 555 31st Street, Downers Grove, Illinois 60515, USA. amayer@midwestern.edu
Abimael D Rodríguez
Roberto G S Berlinck
Mark T Hamann

Funding

Domoic Acid and Neonatal Microglia ActivationR15ES012654 · NIEHS · MIDWESTERN UNIVERSITY · PI MAYER, ALEJANDRO M · 2004 to 2004
$189k
NIEHS NIH HHS 1R15 ES012654NIEHS NIH HHS R15 ES012654PHS HHS 1R01A136596
6 · The paper itself

Abstract

The current marine pharmacology review that covers the peer-reviewed literature during 2003 and 2004 is a sequel to the authors' 1998-2002 reviews, and highlights the preclinical pharmacology of 166 marine chemicals derived from a diverse group of marine animals, algae, fungi and bacteria. Anthelmintic, antibacterial, anticoagulant, antifungal, antimalarial, antiplatelet, antiprotozoal, antituberculosis or antiviral activities were reported for 67 marine chemicals. Additionally 45 marine compounds were shown to have significant effects on the cardiovascular, immune and nervous system as well as possessing anti-inflammatory effects. Finally, 54 marine compounds were reported to act on a variety of molecular targets and thus may potentially contribute to several pharmacological classes. Thus, during 2003-2004, research on the pharmacology of marine natural products which involved investigators from Argentina, Australia, Brazil, Belgium, Canada, China, France, Germany, India, Indonesia, Israel, Italy, Japan, Mexico, Morocco, the Netherlands, New Zealand, Norway, Panama, the Philippines, Portugal, Russia, Slovenia, South Korea, Spain, Thailand, Turkey, United Kingdom, and the United States, contributed numerous chemical leads for the continued global search for novel therapeutic agents with broad spectrum activity.

Indexed as

Marine BiologyAnimalsAnthelminticsAnti-Bacterial AgentsAnticoagulantsAnti-Inflammatory AgentsAntimalarialsAntiprotozoal AgentsAntitubercular AgentsAntiviral AgentsBiological ProductsCardiovascular SystemHumansImmune SystemNervous SystemPlatelet Aggregation InhibitorsAnthelminticsAnti-Bacterial AgentsAnticoagulantsAnti-Inflammatory AgentsAntimalarialsAntiprotozoal AgentsAntitubercular AgentsAntiviral AgentsBiological ProductsPlatelet Aggregation Inhibitors

Identifiers

PMID17392033
PMCPMC2151674

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.